Klea Holding unit Klea Pharmaceuticals logs first UAE order

Reuters2026/09/10 16:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Klea Pharmaceuticals received its first order from UAE distributor Alphamed, part of Al Khayyat Investments; delivery and revenue recognition targeted by year-end.
Transfer of ownership completed for a portfolio of 57 medicines registered with the Emirates Drug Establishment, enabling access to UAE public, private markets.
Regional expansion launched toward Bahrain, Qatar, using UAE regulatory files to shorten registration timelines.
Revenue target reaffirmed at more than AED 8.5 million in 2026, rising to more than AED 200 million by 2032; EBITDA expected positive in 2026.
Leadership strengthened with Imad Khalfi as Chief Commercial Officer, Abbas Deesawala as Chief Strategy Officer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klea Holding published the original content used to generate this news brief on September 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Klea Holding unit Klea Pharmaceuticals logs first UAE order

You may also like

Crypto prices